Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease Alchemab using unique approach to explore adaptive immunity identifying naturally protective antibodies in 'resilient patients' to specific diseases Innovate UK Grant to support the finding of a disease-modifying therapy for Huntington's disease (HD), a degenerative disease with no cure and no therapies to prevent progression Alchemab is working in collaboration with Medicines Discovery Catapult, a not-for-profit, government-funded organisation supporting UK life science innovators H...